U.S. markets closed
  • S&P 500

    3,825.33
    +39.95 (+1.06%)
     
  • Dow 30

    31,097.26
    +321.86 (+1.05%)
     
  • Nasdaq

    11,127.84
    +99.14 (+0.90%)
     
  • Russell 2000

    1,727.76
    +19.77 (+1.16%)
     
  • Crude Oil

    108.82
    +0.39 (+0.36%)
     
  • Gold

    1,813.00
    +11.50 (+0.64%)
     
  • Silver

    19.81
    +0.14 (+0.73%)
     
  • EUR/USD

    1.0432
    +0.0005 (+0.05%)
     
  • 10-Yr Bond

    2.8890
    0.0000 (0.00%)
     
  • GBP/USD

    1.2098
    -0.0005 (-0.04%)
     
  • USD/JPY

    135.2880
    +0.1130 (+0.08%)
     
  • BTC-USD

    19,128.15
    +5.63 (+0.03%)
     
  • CMC Crypto 200

    413.10
    -7.04 (-1.68%)
     
  • FTSE 100

    7,168.65
    -0.63 (-0.01%)
     
  • Nikkei 225

    26,139.52
    +203.90 (+0.79%)
     

908 Devices to Participate in Upcoming Investor Conferences

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

BOSTON, February 08, 2022--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will participate in the following virtual investor conferences.

  • 11th Annual SVB Leerink Global Healthcare Conference
    Fireside Chat on Thursday, February 17th at 5:40 a.m. Pacific Time / 8:40 a.m. Eastern Time

  • Cowen 42nd Annual Health Care Conference
    Fireside Chat on Tuesday, March 8th at 8:10 a.m. Pacific Time / 11:10 a.m. Eastern Time

Interested parties may access a live and archived webcast of the virtual sessions on the "Investors" section of the company website at: www.908devices.com.

About 908 Devices

908 Devices Inc. (Nasdaq: MASS) is democratizing laboratory mass spectrometry with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma / biopharma, forensics, and adjacent markets. The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic separations, software automation, and machine learning.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220208005067/en/

Contacts

Investor Contact
Carrie Mendivil
IR@908devices.com